Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA

about

Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA

Item

http://www.wikidata.org/entity/Q56790547

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Relapse prevention: a cost-eff ...... with schizophrenia in the USA

@en

Relapse prevention: a cost-eff ...... with schizophrenia in the USA

@nl

type

Item

label

Relapse prevention: a cost-eff ...... with schizophrenia in the USA

@en

Relapse prevention: a cost-eff ...... with schizophrenia in the USA

@nl

prefLabel

Relapse prevention: a cost-eff ...... with schizophrenia in the USA

@en

Relapse prevention: a cost-eff ...... with schizophrenia in the USA

@nl

P1476

Relapse prevention: a cost-eff ...... with schizophrenia in the USA

@en

P2093

Amy M Duhig

http://www.w3.org/2001/XMLSchema#string

Christophe Sapin

http://www.w3.org/2001/XMLSchema#string

Myrlene S Aigbogun

http://www.w3.org/2001/XMLSchema#string

Siddhesh A Kamat

http://www.w3.org/2001/XMLSchema#string

Sizhu Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.

Schizophrenia relapse, patient considerations, and potential role of lurasidone

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Cost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States.

Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data.

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: implications for schizophrenia treatment.

Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study

Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients.

Practice guideline for the treatment of patients with schizophrenia, second edition.

P304

443-456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CEOR.S160252

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Leslie Citrome

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30147350

http://www.w3.org/2001/XMLSchema#string

P921

health policy

schizophrenia

P932

6101022

http://www.w3.org/2001/XMLSchema#string